-
Mashup Score: 0
Researchers tracked data from more than 200 patients who underwent PCI from August 2020 to July 2022, sharing their findings in JACC: Cardiovascular Interventions.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 2Sexual Minorities See Sharpest Impact of SDOH on CV Health - 9 day(s) ago
These factors negatively affect not just LGBTQ+ but also heterosexual individuals, though to a lesser degree.
Source: www.tctmd.comCategories: General Medicine News, CardiologistsTweet-
A recent #JACC study found that #SDOH are detrimental to CV health for sexual minorities. Read more: https://t.co/vl327NsXsp
-
-
Mashup Score: 0
Researchers tracked data from more than 200 patients who underwent PCI from August 2020 to July 2022, sharing their findings in JACC: Cardiovascular Interventions.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet-
Compared to a paclitaxel-coated balloon, the use of a biolimus-coated balloon might not be as effective in preventing coronary in-stent restenosis after #PCI, according to a new study in #JACCINT. Learn more about the findings with @CardioBusiness: https://t.co/B4QoLFkpgc
-
-
Mashup Score: 0
The data are observational but intuitive, say experts. Further work might define where T-TEER’s greatest benefit lies.
Source: www.tctmd.comCategories: General Medicine News, Cardiology News and JournTweet-
For #vhdTR patients, the extent of the disease could influence 1 year mortality after T-TEER, according to a new study in #JACCINT. @TCTMD discusses the findings: https://t.co/dHSNFtQO1h
-
-
Mashup Score: 4
In the absence of full guidelines, this expert consensus decision pathway gives practical advice for clinicians.
Source: www.tctmd.comCategories: General Medicine News, CardiologistsTweet-
A new ACC expert consensus decision pathway provides guidance for clinicians on #Myocarditis diagnosis and care. Get the highlights with @TCTMD: https://t.co/FdjL8X02rD #CardioX
-
-
Mashup Score: 2Sexual Minorities See Sharpest Impact of SDOH on CV Health - 12 day(s) ago
These factors negatively affect not just LGBTQ+ but also heterosexual individuals, though to a lesser degree.
Source: www.tctmd.comCategories: General Medicine News, CardiologistsTweet-
A recent #JACC study found that #SDOH are detrimental to CV health for sexual minorities. Read more: https://t.co/vl327NsXsp
-
-
Mashup Score: 0
Adding the PCSK9 inhibitor led to greater absolute reductions in CVD risk than in younger patients, with no signs of safety risk.
Source: www.tctmd.comCategories: General Medicine News, CardiologistsTweet-
Elderly #ASCVD patients treated with the #PCSK9 evolocumab derive similar clinical benefit as younger patients, according to a new analysis in #JACC. https://t.co/HfeZq5xvH3 @TCTMD
-
-
Mashup Score: 2Media Alert: ACC to Host Cardio-oncology Conference in Washington and Virtually - American College of Cardiology - 16 day(s) ago
Contact: Katie Glenn, kglenn@acc.org, As novel and established cancer treatments have increased survivors of all kinds of cancers, many of these therapeutics are associated with both short- and long-term cardiovascular effects. For many patients, one of the greatest risks is related to early and late cardiovascular toxicities. The cardio-oncology field strives to provide comprehensive cardiac care to patients undergoing cancer treatment and beyond for those with existing heart disease or experiencing
Source: www.acc.orgCategories: General Medicine News, CardiologistsTweet-
ACC’s #CardioOnc conference is an interdisciplinary & inter-specialty conference designed to provide clinicians with the tools needed to improve the cardiovascular care of cancer patients in everyday practice. Get the details: https://t.co/GJHCyt1iFq https://t.co/CxAigHozwm
-
-
Mashup Score: 0Cardiovascular Disease Medications Underused Globally - American College of Cardiology - 19 day(s) ago
Contact: Olivia Walther, owalther@acc.org, Secondary prevention medications for cardiovascular diseases (CVD) are underused globally and additional strategies to increase their use are needed to improve CVD management and reduce premature mortality rates, according to study published today in JACC, the flagship journal of the American College of Cardiology. The study observed participants with CVD from 17 coun tries over 12 years and found that medication use remains low with little improvement. Secondary
Source: www.acc.orgCategories: General Medicine News, CardiologistsTweet-
Secondary prevention medications for #CVD are underused globally and additional strategies to increase their use are needed to improve CVD management and reduce premature mortality rates, according to a study published in #JACC. Read more: https://t.co/pC3yIsFuFi https://t.co/ElBY8UlwPC
-
-
Mashup Score: 0Noisy Settings OK For Blood Pressure Testing - 22 day(s) ago
TUESDAY, Jan. 28, 2025 (HealthDay News) — Don’t worry if someone’s checking your blood pressure in a loud public place.The reading they get is apt to be just a
Source: www.healthday.comCategories: General Medicine News, CardiologistsTweet-
Blood pressure readings are just as accurate in noisy settings as quiet environments, according to a new study. Find out more: https://t.co/wRWMHRbRLg @HealthDayTweets #CardioX
-
Compared to a paclitaxel-coated balloon, the use of a biolimus-coated balloon might not be as effective in preventing coronary in-stent restenosis after #PCI, according to a new study in #JACCINT. Learn more about the findings with @CardioBusiness: https://t.co/B4QoLFkpgc